Nisa Investment Advisors LLC Dramatically Reduces Holdings in LivaNova PLC in First Quarter

August 11, 2023

🌥️Trending News

LIVANOVA ($NASDAQ:LIVN): LivaNova PLC is a U.K.-based medical technology company focused on the development and commercialization of medical devices and therapies for cardiovascular, neurological, and other diseases. Its shares are traded on the London Stock Exchange (LSE). Nisa Investment Advisors LLC has made a dramatic reduction of its holdings in LivaNova PLC in the first quarter. This was revealed in the firm’s most recent disclosure, which showed that their stake in the company had been reduced by 73.6%. This could be seen as a vote of no confidence in the medical technology firm, as the holding company has significantly reduced its exposure to the company’s stock.

However, it could be seen as a sign of caution on their part, as the company has seen significant volatility in its share price recently. With this significant reduction in their stake, investors will be sure to keep an eye on the developments surrounding LivaNova PLC to see how they fare in the future.

Market Price

On Monday, LIVANOVA PLC stock opened at $57.1 and closed at $57.4, up by 0.6% from the previous closing price of 57.1. While the reduced shareholding may have had a negative effect on the stock’s performance, it managed to close 0.6% higher despite this news. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Livanova Plc. More…

    Total Revenues Net Income Net Margin
    1.08k -97.16 -5.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Livanova Plc. More…

    Operations Investing Financing
    57.16 -34.92 102.35
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Livanova Plc. More…

    Total Assets Total Liabilities Book Value Per Share
    2.34k 1.1k 23.05
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Livanova Plc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    3.4% -5.3% -2.8%
    FCF Margin ROE ROA
    2.6% -1.5% -0.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale recently conducted an analysis of LIVANOVA PLC‘s wellbeing, and the results were interesting. The Star Chart classified LIVANOVA PLC as an “elephant” type of company – meaning that after deducting off liabilities, it is still rich in assets. This makes it an attractive investment for the right kind of investors. Looking closer at the company’s wellbeing, we found that LIVANOVA PLC had an intermediate health score of 6/10. This suggests that it is strong enough to ride out any sort of crisis without the risk of bankruptcy, thanks to its strong cashflows and relatively low debt. That being said, there are a few areas where LIVANOVA PLC could stand to improve. For example, it has a relatively weak dividend and growth performance compared to its strong profitability. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The company’s products include implantable cardioverter defibrillators, pacemakers, percutaneous transluminal coronary angioplasty catheters, stents, and thrombectomy devices. LivaNova PLC operates in Europe, the United States, Asia Pacific, the Middle East, and Africa. The company was formerly known as Sorin Group S.p.A. and changed its name to LivaNova PLC in February 2016. LivaNova PLC was founded in 1956 and is headquartered in London, the United Kingdom. LivaNova PLC’s competitors include MicroPort Scientific Corp, Fukuda Denshi Co Ltd, and PetVivo Holdings Inc.

    – MicroPort Scientific Corp ($SEHK:00853)

    MicroPort Scientific Corp is a medical device company that develops, manufactures, and markets a broad range of products and solutions for the treatment of cardiovascular diseases. The company has a market cap of 31.83B as of 2022 and a return on equity of -19.11%. MicroPort’s products and solutions are used in a variety of procedures, including coronary angioplasty, stenting, and valve replacement. The company’s products are sold in over 50 countries worldwide.

    – Fukuda Denshi Co Ltd ($TSE:6960)

    With a market cap of 114.93B as of 2022, Fukuda Denshi Co Ltd is one of the largest companies in Japan. The company produces a wide range of products, including medical equipment, electronic products, and communications equipment. The company has a strong reputation for quality and innovation, and is a major player in the global market. Fukuda Denshi Co Ltd has a return on equity of 9.95%, which is relatively high for a large company. The company’s strong financial performance is due in part to its efficient operations and sound management.

    – PetVivo Holdings Inc ($NASDAQ:PETV)

    PetVivo Holdings Inc is a pet health and wellness company that focuses on the development and commercialization of pet health products. The company has a market capitalization of $25.78 million and a return on equity of -79.79%. The company’s products include a line of CBD-based pet health products, as well as a line of pet supplements.


    LivaNova PLC (LIVN), a medical device company, has been the subject of recent investing analysis. This move signals a potential decline in confidence among investors for the company. Analysts are keeping an eye on overall sentiment in the market, the company’s performance, and potential changes in the industry that may influence investor decisions about LivaNova in the coming quarters.

    Recent Posts

    Leave a Comment